b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29655981</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>12</Month>\n            <Day>27</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>12</Month>\n            <Day>27</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1464-3405</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>28</Volume>\n                    <Issue>10</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>06</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Bioorganic &amp; medicinal chemistry letters</Title>\n                <ISOAbbreviation>Bioorg. Med. Chem. Lett.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Modular synthesis of new C-aryl-nucleosides and their anti-CML activity.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1931-1936</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0960-894X(18)30258-0</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bmcl.2018.03.063</ELocationID>\n            <Abstract>\n                <AbstractText>The C-aryl-ribosyles are of utmost interest for the development of antiviral and anticancer agents. Even if several synthetic pathways have been disclosed for the preparation of these nucleosides, a direct, few steps and modular approaches are still lacking. In line with our previous efforts, we report herein a one step - eco-friendly \xce\xb2-ribosylation of aryles and heteroaryles through a direct Friedel-Craft ribosylation mediated by bismuth triflate, Bi(OTf)<sub>3</sub>. The resulting carbohydrates have been functionalized by cross-coupling reactions, leading to a series of new C-aryl-nucleosides (32 compounds). Among them, we observed that 5d exerts promising anti-proliferative effects against two human Chronic Myeloid Leukemia (CML) cell lines, both sensitive (K562-S) or resistant (K562-R) to imatinib, the &quot;gold standard of care&quot; used in this pathology. Moreover, we demonstrated that 5d kills CML cells by a non-conventional mechanism of cell death.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018. Published by Elsevier Ltd.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Marzag</LastName>\n                    <ForeName>Hamid</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 C\xc3\xb4te d\'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 06108 Nice, France; Plant Chemistry, Organic and Bioorganic Synthesis Team, URAC23, Faculty of Sciences, B.P. 1014, GEOPAC Research Center, Mohammed V University, Rabat, Morocco.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zerhouni</LastName>\n                    <ForeName>Marwa</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 C\xc3\xb4te d\'Azur, INSERM U1065, Centre M\xc3\xa9diterran\xc3\xa9en de M\xc3\xa9decine Mol\xc3\xa9culaire (C3M), B\xc3\xa2timent ARCHIMED, 151 Route de Saint-Antoine de Ginesti\xc3\xa8re, BP 2 3194, 06204 Nice Cedex 3, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tachallait</LastName>\n                    <ForeName>Hamza</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 C\xc3\xb4te d\'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 06108 Nice, France; Plant Chemistry, Organic and Bioorganic Synthesis Team, URAC23, Faculty of Sciences, B.P. 1014, GEOPAC Research Center, Mohammed V University, Rabat, Morocco.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Demange</LastName>\n                    <ForeName>Luc</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 C\xc3\xb4te d\'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 06108 Nice, France; D\xc3\xa9partement de Chimie, Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, UFR des Sciences Pharmaceutiques, 4 avenue de l\'Observatoire &amp; UFR Biom\xc3\xa9dicale des Saints P\xc3\xa8res, 45 rue des Saints P\xc3\xa8res, Paris Fr-75006, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Robert</LastName>\n                    <ForeName>Guillaume</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 C\xc3\xb4te d\'Azur, INSERM U1065, Centre M\xc3\xa9diterran\xc3\xa9en de M\xc3\xa9decine Mol\xc3\xa9culaire (C3M), B\xc3\xa2timent ARCHIMED, 151 Route de Saint-Antoine de Ginesti\xc3\xa8re, BP 2 3194, 06204 Nice Cedex 3, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bougrin</LastName>\n                    <ForeName>Khalid</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Plant Chemistry, Organic and Bioorganic Synthesis Team, URAC23, Faculty of Sciences, B.P. 1014, GEOPAC Research Center, Mohammed V University, Rabat, Morocco.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Auberger</LastName>\n                    <ForeName>Patrick</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 C\xc3\xb4te d\'Azur, INSERM U1065, Centre M\xc3\xa9diterran\xc3\xa9en de M\xc3\xa9decine Mol\xc3\xa9culaire (C3M), B\xc3\xa2timent ARCHIMED, 151 Route de Saint-Antoine de Ginesti\xc3\xa8re, BP 2 3194, 06204 Nice Cedex 3, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Benhida</LastName>\n                    <ForeName>Rachid</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 C\xc3\xb4te d\'Azur, CNRS, Institut de Chimie de Nice UMR 7272, 06108 Nice, France; Mohamed VI Polytechnic University, UM6P, 43150 Ben Guerir, Morocco. Electronic address: benhida@unice.fr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>03</Month>\n                <Day>24</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Bioorg Med Chem Lett</MedlineTA>\n            <NlmUniqueID>9107377</NlmUniqueID>\n            <ISSNLinking>0960-894X</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008698">Mesylates</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D009705">Nucleosides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>51KD8E1741</RegistryNumber>\n                <NameOfSubstance UI="C445789">Bi(OTf)3</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>8A1O1M485B</RegistryNumber>\n                <NameOfSubstance UI="D000068877">Imatinib Mesylate</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002384" MajorTopicYN="N">Catalysis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000068877" MajorTopicYN="N">Imatinib Mesylate</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020014" MajorTopicYN="N">K562 Cells</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015464" MajorTopicYN="N">Leukemia, Myelogenous, Chronic, BCR-ABL Positive</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008698" MajorTopicYN="N">Mesylates</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009705" MajorTopicYN="N">Nucleosides</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Anti-CML agents</Keyword>\n            <Keyword MajorTopicYN="Y">Green chemistry</Keyword>\n            <Keyword MajorTopicYN="Y">Modular syntheses</Keyword>\n            <Keyword MajorTopicYN="Y">Nucleoside analogues</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>02</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>03</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>4</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>4</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29655981</ArticleId>\n            <ArticleId IdType="pii">S0960-894X(18)30258-0</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.bmcl.2018.03.063</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'